09:07 AM EST, 12/11/2024 (MT Newswires) -- CareDx ( CDNA ) and TC Biopharm ( TCBP ) said Wednesday they have struck a partnership under which CareDx ( CDNA ) will carry out pharmacokinetic analysis through its AlloCell test in the Achieve clinical study of allogeneic gamma delta T cell therapy TCB008.
Financial terms weren't disclosed.
The trial will evaluate the effectiveness and efficacy of TCB008 for participants with acute myeloid leukemia or myelodysplastic syndrome, the companies added.